Literature DB >> 34310757

Dermatoses caused by face mask wearing during the COVID-19 pandemic.

O Yu Olisova1, N P Teplyuk1, E V Grekova1, A A Lepekhova1.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34310757      PMCID: PMC8447160          DOI: 10.1111/jdv.17546

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   9.228


× No keyword cloud information.

Conflict of interest

None declared. Editor We present 6 patients with different dermatoses caused by face mask wearing during the COVID‐19 pandemic. Physical examination revealed lesions only under masks. Two 20 years old females presented to our clinic with the pustules and papules on the face area. Due to the COVID‐19 pandemic, the patients began to use neoprene mask with daily change. The first papules and pustules appeared in the mask area about two weeks of mask using. The diagnosis of mask induced acne (‘maskne’) was made (Fig. 1a‐c).
Figure 1

(a) Patient 1: A 20‐year‐old female with the pustules and papules on the chin, cheeks and nasal bridge; (b,c) Patient 2: A 20‐year‐old female with the pustules and papules on the chin, cheeks and nasal bridge.

(a) Patient 1: A 20‐year‐old female with the pustules and papules on the chin, cheeks and nasal bridge; (b,c) Patient 2: A 20‐year‐old female with the pustules and papules on the chin, cheeks and nasal bridge. Two 25 and 23 years old patients presented with irregular pink‐yellow patches with sharp borders and small serous crusts. No concomitant disorders, professional harm and bad habits (smoking, alcohol or drugs) were noted. The lesions had a week history after using mask during 9 months. The patients used neoprene masks changed only once a week. Clinical changes were consistent with the diagnosis of impetigo (Fig. 2a,b).
Figure 2

(a) Patient 3. A 25‐year‐old male with irregular pink‐yellow patches with sharp borders; (b) Patient 4. A 23‐year‐old male with irregular pink‐yellow patches with sharp borders and multiple small serous crusts; (c) Patient 5. A 54‐year‐old female with central facial erythema and papulopustular lesions; (d) Patient 6. A 50‐year‐old female with pink erythema and erythematous‐grouped papules on the chin, cheeks and nasal bridge.

(a) Patient 3. A 25‐year‐old male with irregular pink‐yellow patches with sharp borders; (b) Patient 4. A 23‐year‐old male with irregular pink‐yellow patches with sharp borders and multiple small serous crusts; (c) Patient 5. A 54‐year‐old female with central facial erythema and papulopustular lesions; (d) Patient 6. A 50‐year‐old female with pink erythema and erythematous‐grouped papules on the chin, cheeks and nasal bridge. A 54‐year‐old woman had rosacea with central facial erythema with papulopustular lesions during three years. Minocycline and ivermectin (IVM) 1% cream treatment provided remission during 1.5 years. When the COVID‐19 pandemic began, the patient used surgical mask that she changed every four hours. Prolonged use of masks provoked exacerbation of the rosacea. Over a 3‐week treatment with IVM 1% cream, a marked clinical improvement was observed. During the next 4 months, the patient did not use mask, lived in a village, ordered groceries via internet and had a complete remission of rosacea. After quarantine, the patient moved to the city. The rosacea recurred with central facial erythema with papulopustular lesions under the mask (Fig. 2c). A 50‐year‐old woman presented to the Dermatology Clinic with a rash around the mouth and the nose and complaints of burning. Physical examination revealed pink erythema with erythematous‐grouped papules. The vermillion borders of the lips were spared. Clinical changes were consistent with the diagnosis of perioral dermatitis (Fig. 2d). The rashes were associated with the beginning of mask wearing. First foci of erythema appeared a month later. The patient used surgical masks. She had chronic gastritis in remission. Since the COVID‐19 (SARS‐COV‐2) pandemic began, mask wearing like personal protective equipment (PPE) was advocated to prevent droplet dispersal during sneezing, coughing and talking. Using masks as a part of PPE has become obligatory for not only healthcare professionals but every person. , As of yet, several facial dermatoses such as acne, rosacea, seborrheic dermatitis, perioral dermatitis, impetigo as a secondary reaction to prolonged use of PPE have been sharply increased in the dermatologist practice. , , Due to the mask regimen, a new term ‘maskne’ was introduced for acne caused by mask wearing. , Prolonged mask use causes exacerbation of not only pre‐existing facial dermatoses (acne, rosacea or perioral dermatitis) but also increases the incidence of acne mechanica, occupational dermatitis (both irritant contact dermatitis and allergic contact dermatitis) caused by the mask material and prolonged contact with straps. Increased warmth and dampness of the face skin due to expired air and sweating caused occlusive effect hampering the skin hydration and irritating pilosebaceous glands ducts with changes in skin microflora. , A lengthy daily non‐changed mask wearing leads to S. aureus activation and causes an infection, for instance, impetigo. Mask‐related lesions involve chin, cheeks and nasal bridge. These areas could be potentially a focus for preventative measures. To avoid mask‐associated facial dermatoses, dermatologists counsel patients with the help of mass media and individually regarding the proper skin hygiene: to avoid over cleansing, to use mild cleansers close to skin’s natural pH (pH 5) and to add non‐comedogenic moisturizing creams.

Funding sources

None declared.
  5 in total

1.  A case of goggle-mask-related impetigo at the time of the COVID-19 pandemic.

Authors:  Qian Yu; Wei Li; Lianjuan Yang
Journal:  Dermatol Ther       Date:  2020-06-13       Impact factor: 3.858

2.  Increased flare of acne caused by long-time mask wearing during COVID-19 pandemic among general population.

Authors:  Changxu Han; Jialiang Shi; Yan Chen; Zhenying Zhang
Journal:  Dermatol Ther       Date:  2020-07-02       Impact factor: 3.858

3.  Occupational dermatitis to facial personal protective equipment in health care workers: A systematic review.

Authors:  Jiade Yu; Jennifer K Chen; Christen M Mowad; Margo Reeder; Sara Hylwa; Sarah Chisolm; Cory A Dunnick; Ari M Goldminz; Sharon E Jacob; Peggy A Wu; Jonathan Zippin; Amber Reck Atwater
Journal:  J Am Acad Dermatol       Date:  2020-10-01       Impact factor: 11.527

4.  Facial dermatoses in the general population due to wearing of personal protective masks during the COVID-19 pandemic: first observations after lockdown.

Authors:  S Giacalone; A Minuti; C B Spigariolo; E Passoni; G Nazzaro
Journal:  Clin Exp Dermatol       Date:  2020-08-26       Impact factor: 4.481

5.  Personal protective equipment induced facial dermatoses in healthcare workers managing Coronavirus disease 2019.

Authors:  M Singh; M Pawar; A Bothra; A Maheshwari; V Dubey; A Tiwari; A Kelati
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-02       Impact factor: 9.228

  5 in total
  4 in total

1.  What type of face mask should we choose in coronavirus disease 2019 pandemic considering photoprotective effectiveness?

Authors:  Sung Jin Park; Jun Hyuk Cho; Min Seok Ham; Soo Hong Seo; Hyo Hyun Ahn; Dai Hyun Kim
Journal:  Photodermatol Photoimmunol Photomed       Date:  2022-03-30       Impact factor: 3.254

2.  Reply to "Dermatoses caused by face mask wearing during the COVID-19 pandemic".

Authors:  F Bardazzi; L Sacchelli; C Loi; F Filippi; A Guglielmo
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-02-23       Impact factor: 6.166

3.  The Association Between Facial Dermatosis and Face-Mask Wearing During COVID-19 in Saudi Arabia.

Authors:  Hatoon M Althobaiti; Hend Althobaiti; Muhammad Khan; Hanadi Alsatti; Sahal J Samarkandy
Journal:  Cureus       Date:  2022-02-15

4.  The change in the frequency and severity of facial dermatoses and complaints in healthcare workers during the COVID-19.

Authors:  Nur Cihan Cosansu; Gulcan Yuksekal; Omer Kutlu; Mutlu Umaroglu; Mahizer Yaldız; Bahar Sevimli Dikicier
Journal:  J Cosmet Dermatol       Date:  2022-06-02       Impact factor: 2.189

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.